Facebook's CFO is joining the board of a biotech company trying to cure Alzheimer's disease

Facebook CFO David Wehner is one of three new board members appointed to Alector, a company taking an innovative approach to curing Alzheimer's. The other two are 23andMe's chief science officer, Richard Scheller, and ex-Genentech CFO Louis Lavigne.